Search

everythinglearnresearchcommunity

for

Search:↓

Patients with psoriasis ranked symptom control and treatment efficacy as most important for their care.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

EPDS is a rare, chronic scalp condition that's hard to treat and needs better awareness for improved outcomes.

Scalp psoriasis inflammation is mainly caused by bacteria-related triggers.

Tofacitinib may be an effective and safe treatment for adolescent alopecia areata.

Platelet Rich Plasma reduces psoriasis symptoms but isn't enough alone for treatment.

Nanomedicines could offer better, longer-lasting psoriasis treatments with fewer side effects.

Shampoos with specific ingredients are effective and safe for treating scalp psoriasis.

Psoriatic alopecia is a challenging hair loss condition linked to psoriasis, needing better diagnosis and personalized treatments.

Repeated biopsies are crucial for managing lupus panniculitis when initial treatments fail.

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

A woman's severe hair loss was caused by scalp psoriasis, not the initially thought condition, and treatment improved her psoriasis but couldn't restore her lost hair.

Psoriasis lesions have fewer and smaller oil glands, which might affect the condition's development.

Scalp pemphigus vulgaris can be effectively treated with low-dose prednisone and triamcinolone.

Personalized medicine is important for treating skin disorders, with new treatments and connections to hormones and genetics being explored.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Alopecia areata does not affect areas with psoriasis plaques.

S100A7 and IL-17 may contribute to inflammation in lichen planopilaris.

The conclusion is that Erosive Pustular Dermatosis of the Scalp is a rare condition best treated with strong topical steroids and sometimes systemic treatment.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Psoriasis is the most common cause of erythroderma, and proper medical follow-up is crucial.

Chronic scalp lesions with crusts and pus that heal with strong topical steroids suggest Erosive Pustular Dermatosis, confirmed by biopsy showing specific immune cells.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Systemic therapies improve nail psoriasis but have high side effects; more research is needed.

High-potency steroids or tacrolimus are effective treatments for Erosive Pustular Dermatosis of the Scalp.

The treatment cleared psoriasis in some patients but caused side effects in most.

Animal models help study psoriasis but have limitations and don't fully mimic the human disease.

Ixekizumab quickly and effectively clears palmoplantar psoriasis in both adults and children.

Early diagnosis and treatment are crucial for managing alopecia areata, morphea, and psoriasis.